Information:
Fel:
ID
30970
Beskrivning
Efficacy and Safety of Methylprednisolone Per os Versus IV for the Treatment of Multiple Sclerosis (MS) Relapses; ODM derived from: https://clinicaltrials.gov/show/NCT00984984
Länk
https://clinicaltrials.gov/show/NCT00984984
Nyckelord
Versioner (1)
- 2018-07-08 2018-07-08 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
8 juli 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Multiple Sclerosis, Relapsing-Remitting NCT00984984
Eligibility Multiple Sclerosis, Relapsing-Remitting NCT00984984
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis, Relapsing-Remitting NCT00984984
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age
Item
age 18 to 55
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
informed written consent
boolean
C0021430 (UMLS CUI [1])
Multiple Sclerosis, Relapsing-Remitting
Item
multiple sclerosis (mc donald criteria, relapsing-remitting
boolean
C0751967 (UMLS CUI [1])
EDSS Before Relapse
Item
edss before relapse : 0 to 5
boolean
C0451246 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0035020 (UMLS CUI [1,3])
C0332152 (UMLS CUI [1,2])
C0035020 (UMLS CUI [1,3])
Relapse | Expanded disability status scale score increased | Symptoms Duration
Item
relapse : increase of 1 point or more for 1 or more functional systems of kurtzke, with sf score most affected > 1 for all functions except for sensory (> 2); duration of symptoms > 24 h
boolean
C0035020 (UMLS CUI [1])
C3203539 (UMLS CUI [2])
C1457887 (UMLS CUI [3,1])
C0449238 (UMLS CUI [3,2])
C3203539 (UMLS CUI [2])
C1457887 (UMLS CUI [3,1])
C0449238 (UMLS CUI [3,2])
Fever
Item
fever
boolean
C0015967 (UMLS CUI [1])
Relapse Previous | Steroid therapy Before Relapse
Item
previous relapse, and/or corticosteroid treatment < 1 month before present relapse
boolean
C0035020 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0149783 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
C0035020 (UMLS CUI [2,3])
C0205156 (UMLS CUI [1,2])
C0149783 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
C0035020 (UMLS CUI [2,3])
Relapse Symptoms First
Item
first symptoms of the present relapse appeared > 15 days before inclusion
boolean
C0035020 (UMLS CUI [1,1])
C1457887 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C1457887 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
Mitoxantrone | Cyclophosphamide | natalizumab
Item
under mitoxantrone of cyclophosphamid or natalizumab treatment
boolean
C0026259 (UMLS CUI [1])
C0010583 (UMLS CUI [2])
C1172734 (UMLS CUI [3])
C0010583 (UMLS CUI [2])
C1172734 (UMLS CUI [3])
Diabetes Mellitus
Item
diabetes
boolean
C0011849 (UMLS CUI [1])
Communicable Disease Uncontrolled
Item
infection not under control
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,2])
Liver Failure | Kidney Failure
Item
liver or kidney failure
boolean
C0085605 (UMLS CUI [1])
C0035078 (UMLS CUI [2])
C0035078 (UMLS CUI [2])
Psychiatric symptoms Uncontrolled
Item
psychiatric symptoms not under control
boolean
C0233401 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,2])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Methylprednisolone allergy
Item
hypersensibility to methylprednisolone
boolean
C0571614 (UMLS CUI [1])